ES2179193T3 - Combinaciones sinergicas de zidovudina, 1592u89 y 3tc. - Google Patents

Combinaciones sinergicas de zidovudina, 1592u89 y 3tc.

Info

Publication number
ES2179193T3
ES2179193T3 ES96911953T ES96911953T ES2179193T3 ES 2179193 T3 ES2179193 T3 ES 2179193T3 ES 96911953 T ES96911953 T ES 96911953T ES 96911953 T ES96911953 T ES 96911953T ES 2179193 T3 ES2179193 T3 ES 2179193T3
Authority
ES
Spain
Prior art keywords
combinations
zidovudina
hiv
nucleosid
invention refers
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES96911953T
Other languages
English (en)
Spanish (es)
Inventor
David Walter Barry
Clair Martha Heider St
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wellcome Foundation Ltd
Original Assignee
Wellcome Foundation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26306774&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2179193(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GBGB9506489.5A external-priority patent/GB9506489D0/en
Priority claimed from GBGB9506490.3A external-priority patent/GB9506490D0/en
Application filed by Wellcome Foundation Ltd filed Critical Wellcome Foundation Ltd
Application granted granted Critical
Publication of ES2179193T3 publication Critical patent/ES2179193T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Cephalosporin Compounds (AREA)
  • Medicinal Preparation (AREA)
ES96911953T 1995-03-30 1996-03-28 Combinaciones sinergicas de zidovudina, 1592u89 y 3tc. Expired - Lifetime ES2179193T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9506489.5A GB9506489D0 (en) 1995-03-30 1995-03-30 Antiviral combinations
GBGB9506490.3A GB9506490D0 (en) 1995-03-30 1995-03-30 Antiviral combinations

Publications (1)

Publication Number Publication Date
ES2179193T3 true ES2179193T3 (es) 2003-01-16

Family

ID=26306774

Family Applications (1)

Application Number Title Priority Date Filing Date
ES96911953T Expired - Lifetime ES2179193T3 (es) 1995-03-30 1996-03-28 Combinaciones sinergicas de zidovudina, 1592u89 y 3tc.

Country Status (35)

Country Link
US (1) US6417191B1 (OSRAM)
EP (1) EP0817637B1 (OSRAM)
JP (1) JP2954357B2 (OSRAM)
KR (1) KR100542536B1 (OSRAM)
CN (1) CN1103593C (OSRAM)
AP (1) AP652A (OSRAM)
AT (1) ATE220551T1 (OSRAM)
AU (1) AU715213B2 (OSRAM)
BR (3) BRPI9612992B1 (OSRAM)
CA (1) CA2216634C (OSRAM)
CZ (1) CZ295940B6 (OSRAM)
DE (3) DE69622386T2 (OSRAM)
DK (1) DK0817637T3 (OSRAM)
EA (1) EA000626B3 (OSRAM)
EE (1) EE04047B1 (OSRAM)
ES (1) ES2179193T3 (OSRAM)
FR (1) FR05C0022I2 (OSRAM)
GE (1) GEP20022647B (OSRAM)
HU (1) HU224010B1 (OSRAM)
IL (1) IL117727A (OSRAM)
LU (1) LU91171I2 (OSRAM)
MX (1) MX9707316A (OSRAM)
MY (1) MY115461A (OSRAM)
NL (1) NL300195I2 (OSRAM)
NO (2) NO313787B1 (OSRAM)
NZ (1) NZ306419A (OSRAM)
OA (1) OA10616A (OSRAM)
PL (1) PL187085B1 (OSRAM)
PT (1) PT817637E (OSRAM)
RO (1) RO117995B1 (OSRAM)
SI (1) SI0817637T1 (OSRAM)
SK (1) SK283825B6 (OSRAM)
TR (1) TR199701074T1 (OSRAM)
UA (1) UA60293C2 (OSRAM)
WO (1) WO1996030025A1 (OSRAM)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997049411A1 (en) 1996-06-25 1997-12-31 Glaxo Group Limited Combinations comprising vx478, zidovudine, ftc and/or 3tc for use in the treatment of hiv
US6113920A (en) * 1996-10-31 2000-09-05 Glaxo Wellcome Inc. Pharmaceutical compositions
TW536403B (en) * 1997-03-24 2003-06-11 Glaxo Group Ltd An ethanol and ethylenediaminetetraacetic acid free pharmaceutical composition comprising lamivudine and exhibiting antimicrobial preservative efficacy
GB9709945D0 (en) * 1997-05-17 1997-07-09 Glaxo Group Ltd A novel salt
AU769660B2 (en) * 1997-05-17 2004-01-29 Glaxo Group Limited Carbocyclic nucleoside hemisulfate and its use in treating viral infections
CA2289655A1 (en) * 1997-05-17 1998-11-26 Glaxo Group Limited Antiviral combinations containing the carbocyclic nucleoside 1592u89
GB9809213D0 (en) * 1998-04-29 1998-07-01 Glaxo Group Ltd Pharmaceutical compositions
EP1146882A2 (en) * 1998-05-29 2001-10-24 The University Of Florida Combination of zidovudine (azt) with nucleoside analogs for treatment of feline immunodeficiency virus
US6875773B1 (en) 1998-05-29 2005-04-05 Ben M. Dunn Combination therapy for treatment of FIV infection
GB9820417D0 (en) * 1998-09-18 1998-11-11 Glaxo Group Ltd Antiviral combinations
US6432966B2 (en) 1999-10-29 2002-08-13 Smithkline Beecham Corporation Antiviral combinations
US7074417B2 (en) * 2000-10-13 2006-07-11 Advancis Pharmaceutical Corporation Multiple-delayed release anti-viral product, use and formulation thereof
AP2220A (en) * 2001-05-11 2011-03-24 Cipla Medpro Pty Ltd Pharmaceutical composition.
TW200403061A (en) * 2002-06-04 2004-03-01 Glaxo Group Ltd Pharmaceutical compositions
NZ540728A (en) 2003-01-14 2008-08-29 Gilead Sciences Inc Compositions and methods for combination antiviral therapy
KR20050119652A (ko) 2003-03-24 2005-12-21 에프. 호프만-라 로슈 아게 역전사 효소 저해제로서의 벤질-피리다진온
ATE490470T1 (de) 2003-10-24 2010-12-15 Immunaid Pty Ltd Therapieverfahren
TWI471145B (zh) 2005-06-13 2015-02-01 Bristol Myers Squibb & Gilead Sciences Llc 單一式藥學劑量型
KR20080056220A (ko) 2005-10-19 2008-06-20 에프. 호프만-라 로슈 아게 페닐-아세트아마이드 ｎｎｒｔ 저해제
RU2469032C2 (ru) 2006-12-13 2012-12-10 Ф.Хоффманн-Ля Рош Аг Производные 2-(пиперидин-4-ил)-4-фенокси- или фениламинопиримидина в качестве ненуклеозидных ингибиторов обратной транскриптазы
CA2677623C (en) * 2007-02-09 2015-04-07 Alphapharm Pty Ltd A dosage form containing two or more active pharmaceutical ingredients in different physical forms
CA2763373C (en) 2009-05-27 2018-01-09 Immunaid Pty Ltd Methods and systems for determining preferred times for administering therapy to treat diseases
PT3494972T (pt) 2010-01-27 2024-02-12 Viiv Healthcare Co Combinações de dolutegravir e lamivudina para o tratamento de infeção pelo hiv
MX2016002560A (es) 2013-08-29 2016-10-26 Teva Pharma Forma de dosificacion unitaria que comprende emtricitabina, tenofovir, darunavir y ritonavir y un comprimido monolitico que comprende darunavir y ritonavir.
EP3129009A1 (en) 2014-04-08 2017-02-15 Teva Pharmaceutical Industries Ltd Unit dosage form comprising emtricitabine, tenofovir, darunavir and ritonavir
CN106715456B (zh) 2014-08-12 2023-08-29 莫纳什大学 定向淋巴的前药
EP3347340A4 (en) 2015-09-08 2019-01-23 Monash University LYMPHENLEITUNGSPRODRUGS
AU2018324037A1 (en) 2017-08-29 2020-04-16 Monash University Lymphatic system-directing lipid prodrugs
US11883497B2 (en) 2017-08-29 2024-01-30 Puretech Lyt, Inc. Lymphatic system-directing lipid prodrugs
US11608345B1 (en) 2017-12-19 2023-03-21 Puretech Lyt, Inc. Lipid prodrugs of rapamycin and its analogs and uses thereof
US11304954B2 (en) 2017-12-19 2022-04-19 Puretech Lyt, Inc. Lipid prodrugs of mycophenolic acid and uses thereof
WO2021159021A1 (en) 2020-02-05 2021-08-12 Puretech Lyt, Inc. Lipid prodrugs of neurosteroids

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4724232A (en) * 1985-03-16 1988-02-09 Burroughs Wellcome Co. Treatment of human viral infections
US5047407A (en) 1989-02-08 1991-09-10 Iaf Biochem International, Inc. 2-substituted-5-substituted-1,3-oxathiolanes with antiviral properties
US5122517A (en) 1988-06-10 1992-06-16 Regents Of The University Of Minnesota Antiviral combination comprising nucleoside analogs
GB8815265D0 (en) * 1988-06-27 1988-08-03 Wellcome Found Therapeutic nucleosides
US5204466A (en) 1990-02-01 1993-04-20 Emory University Method and compositions for the synthesis of bch-189 and related compounds
GB9009861D0 (en) * 1990-05-02 1990-06-27 Glaxo Group Ltd Chemical compounds
GB9104740D0 (en) 1991-03-06 1991-04-17 Wellcome Found Antiviral nucleoside combination
ES2083668T5 (es) 1991-05-16 2001-06-16 Glaxo Group Ltd Combinaciones antiviricas que contienen analogos de nucleosido.
ATE184787T1 (de) * 1992-05-13 1999-10-15 Wellcome Found Therapeutische kombinationen
US5723490A (en) 1992-09-08 1998-03-03 Vertex Pharmaceuticals Incorporated THF-containing sulfonamide inhibitors of aspartyl protease
GB9417249D0 (en) 1994-08-26 1994-10-19 Wellcome Found A novel salt
US5869461A (en) 1995-03-16 1999-02-09 Yale University Reducing toxicity of L-nucleosides with D-nucleosides
WO1997049411A1 (en) 1996-06-25 1997-12-31 Glaxo Group Limited Combinations comprising vx478, zidovudine, ftc and/or 3tc for use in the treatment of hiv
AU723877C (en) 1996-06-25 2001-08-23 Glaxo Group Limited Combinations comprising VX478, zidovudine and/or 1592U89 for use in the treatment of HIV
DE10226522A1 (de) 2002-06-14 2003-12-24 Degussa Verwendung von Übergangsmetallkomplexen mit stickstoffhaltigen mehrzähnigen Liganden als Bleichkatalysator und Bleichmittelzusammensetzung

Also Published As

Publication number Publication date
NO974510L (no) 1997-09-29
AP652A (en) 1998-06-19
IL117727A0 (en) 1996-07-23
NL300195I1 (nl) 2005-08-01
TR199701074T1 (xx) 1998-02-21
PL322532A1 (en) 1998-02-02
SI0817637T1 (en) 2002-10-31
AU715213B2 (en) 2000-01-20
DE122005000029I2 (de) 2006-04-27
GEP20022647B (en) 2002-03-25
UA60293C2 (uk) 2003-10-15
LU91171I9 (OSRAM) 2018-12-28
MX9707316A (es) 1997-11-29
NO974510D0 (no) 1997-09-29
BR9607851A (pt) 1998-07-21
LU91171I2 (fr) 2005-07-04
OA10616A (en) 2001-03-15
CA2216634A1 (en) 1996-10-03
HUP9801571A3 (en) 2001-04-28
DE122005000029I1 (de) 2005-10-06
NO2005014I1 (no) 2005-06-06
IL117727A (en) 1999-11-30
DE69622386T2 (de) 2003-02-13
NL300195I2 (nl) 2005-11-01
CN1103593C (zh) 2003-03-26
EA199700203A1 (ru) 1998-02-26
CA2216634C (en) 2004-07-20
CZ295940B6 (cs) 2005-12-14
PL187085B1 (pl) 2004-05-31
HK1009401A1 (en) 1999-09-10
CZ309097A3 (cs) 1998-05-13
BR9607851B1 (pt) 2009-01-13
EE9700240A (et) 1998-04-15
CN1185110A (zh) 1998-06-17
NO313787B1 (no) 2002-12-02
AP9701089A0 (en) 1997-10-31
NO2005014I2 (no) 2008-02-11
JPH10511682A (ja) 1998-11-10
FR05C0022I2 (OSRAM) 2005-10-21
HU224010B1 (hu) 2005-04-28
EP0817637A1 (en) 1998-01-14
AU5497296A (en) 1996-10-16
NZ306419A (en) 2000-01-28
PT817637E (pt) 2002-11-29
SK283825B6 (sk) 2004-02-03
EE04047B1 (et) 2003-06-16
RO117995B1 (ro) 2002-12-30
EA000626B3 (ru) 2016-04-29
JP2954357B2 (ja) 1999-09-27
EP0817637B1 (en) 2002-07-17
FR05C0022I1 (OSRAM) 2005-06-10
BRPI9612992B1 (pt) 2020-08-04
US6417191B1 (en) 2002-07-09
DK0817637T3 (da) 2002-11-11
SK129597A3 (en) 1998-07-08
WO1996030025A1 (en) 1996-10-03
MY115461A (en) 2003-06-30
EA000626B1 (ru) 1999-12-29
DE69622386D1 (de) 2002-08-22
HUP9801571A2 (hu) 1999-01-28
KR19980703420A (ko) 1998-11-05
ATE220551T1 (de) 2002-08-15
KR100542536B1 (ko) 2006-03-23
BRPI9607851B8 (pt) 2019-11-05

Similar Documents

Publication Publication Date Title
ES2179193T3 (es) Combinaciones sinergicas de zidovudina, 1592u89 y 3tc.
TW366347B (en) Antiviral pharmaceutical compositions comprising 1,3-oxathiolane nucleoside analogues
BG91270A (bg) Антивирусно и антибактериално средство и метод за използването му
ES2138969T3 (es) Combinacion de nucleosidos antivirales.
ES2069582T3 (es) Nucleosidos terapeuticos.
CA2291994A1 (en) Derivatives and analogues of 2-deoxy-2,3-didehydro-n-acetyl neuraminic acid and their use as antiviral agents
ES2057124T3 (es) Producto terapeutico para el tratamiento de estados peri- o post-menopausicos.
MX9102353A (es) N,o-sulfados de heparosanos, su procedimiento de preparacion y las composiciones farmaceuticas que contienen.
BR9303469A (pt) Conjugado de interferon,composto,processo de preparacao de um conjugado de interferon,use e composicoes farmaceuticas
CA2129995A1 (en) Piperidinyl thiacyclic derivatives
ES2170102T3 (es) Aminociclohexilesteres y utilizacion de los mismos.
ES2170259T3 (es) Empleo de lipidos como agentes auxiliares en la obtencion de formas farmaceuticas solidas segun el procedimiento de extrusion en fusion.
ATE100098T1 (de) Nukleoside, ihre herstellung und pharmazeutische zusammenstellungen.
CA2211802A1 (en) Pharmaceutical composition for the treatment of herpes
EA199700032A1 (ru) Дезинфицирующий состав "велтолен"
RU97101057A (ru) Лечебно-профилактический биопрепарат "бактиспорин"
ES2054718T3 (es) El uso de gepirona para la preparacion de una composicion farmaceutica para el tratamiento de la depresion atipica.
PA8449301A1 (es) Composiciones farmaceuticas
ES2130246T3 (es) Nucleosidos terapeuticos de la serie 2',3'-didesoxi-3'-fluoro-purina.
ZA91115B (en) Topical compositions
ES2189206T3 (es) Beta-alcoxiacrilatos contra la malaria.
ES2189964T3 (es) Combinaciones que comprenden vx478, zidovudina, y 1592u89 para uso en el tratamiento de infecciones por vih.
MX9303985A (es) Nucleosidos terapeuticos.
ATE293445T1 (de) Herstellung reiner stereoisomere von tricyclo- (5.2.1.0(2.6) )-dec-9-yl-xanthogenat sowie deren verwendung als arzneimittel
IL105569A0 (en) Pharmaceutical compositions for the treatment of parkinson's disease

Legal Events

Date Code Title Description
SPCG Supplementary protection certificate granted

Free format text: PRODUCT NAME: ABACAVIR+IAMIVUDINA (KIVEXA); REG.NO/DATE: EU/1/04/293/001-002 20041217

Spc suppl protection certif: 200500026

Filing date: 20050519

Extension date: 20191217

Effective date: 20070521